Paul Hastings Advised TD Securities in Forte Biosciences' Oversubscribed Private Placement
November 21, 2024
November 21, 2024
LOS ANGELES, California, Nov. 21 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.'s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.
The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.
More details can be found here (https . . .
Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.'s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.
The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.
More details can be found here (https . . .